Licensing Agreements
Medical Discoveries, Eucodis sign agreement to develop topical steroidal breast cancer cream
Published in Medical Letter on the CDC and FDA, September 10th, 2006
The agreement provides Eucodis, an Austrian biotechnology company with drug development expertise, exclusive European development rights in exchange for an upfront license fee and milestone payments totaling approximately US$2.5 million. Eucodis maintains responsibility for costs associated with formestane cream's phase 2 trial which is set to commence in 2007. The data collected from these trials will meet the requirements for submission to regulatory bodies, including the U.S. Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Addiction Medicine
Methamphetamine injections increase dopamine turnover - Human Papillomavirus
Cytobrush samples can be used for detection of HPV but not for determining viral load - Nuclear Medicine
Radioactive Drug Research Committee regulations need updating - Q Fever Epidemiology
Epidemiology of human Q fever in United States is reported - Vector-Borne Disease
Egyptian fleas with public health significance were surveyed - Addiction Medicine
GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
